A continuación se referencian las 15 publicaciones más destacadas del grupo de investigación de los últimos 5 años.
(*) Autor correspondencia: (#) igual contribución
1. Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance. Martínez-Román P, Crespo-Bermejo C, Valle-Millares D, Lara-Aguilar V, Arca-Lafuente S, Martín-Carbonero, Ryan P, De los Santos I, López-Huertas MR, Palladino C, Muñoz-Muñoz M, Fernández-Rodríguez A*, Coiras M, Briz V, on behalf of COVIHEP network. Journal of Clinical Medicine 2022, 11: 3579. DOI: https://www.mdpi.com/2077-0383/11/13/3579.
2. Protein Saver® cards: the best alternative for DBS storage at room temperature for HCV RNA. Arca-Lafuente S, Casanueva-Benítez C, Crespo-Bermejo C, Lara-Aguilar V, Martín-Carbonero L, De los Santos I, Madrid R, Briz V*. 903 Scientific Report 2022, 12: 10124. DOI: 10.1038/s41598-022-14375-8.
3. HCV eradication with DAAs differently affects HIV males and females: a whole miRNA sequencing characterization. Valle-Millares D, Brochado-Kith O, Gómez-Sanz A, Martín-Carbonero L, Ryan P, de los Santos I, Castro JM, Troya J, Mayoral-Muñoz M, Cuevas G, Martínez-Román P, Sanz-Sanz J, Muñoz-Muñoz M, Jiménez-Sousa MA, Resino-García S, Briz V#, Fernández-Rodríguez A#. Biomedicine & Pharmacotherapy 2022, 145: 112405. DOI: 10.1016/j.biopha.2021.112405.
4. Persistent Low-Level Viremia in treatment HIV infection: An unresolved status. Crespo-Bermejo C, Ramírez de Arellano E, Lara-Aguilar V, Martínez-Román P, Arca Lafuente S, Gómez-Lus ML, Martín-Carbonero L, Briz V. Virulencia 2021, 12: 2919-2931. DOI: https://doi.org/10.1080/21505594.2021.2004743
5. Diarrhoea-causing enteric protist species in intensively and extensively raised pigs (Sus scrofa domesticus) in Southern Spain. Part II: Association with Hepatitis E virus susceptibility. Rivero-Juarez A, Dashti A, Santín M, George, Köster PC, Lopez-Lopez P, Risalde MA, García-Bocanegra I, Gomez-Villamandos JC, Caballero-Gómez J, Frías M, Bailo B, Ortega S, Muadica AS, Calero-Bernal R, González-Barrio D, Rivero A, Briz V*, Carmena D. Transboundary and Emerging Diseases 2021, 69: e1172-e1178. DOI: https://doi.org/10.1111/tbed.14408.
6. Epidemic history and baseline resistance to NS5A-specific direct acting drugs of Hepatitis C Virus in Spain. Palladino C, Ezeonwumelu IJ, Mate-Cano I, Borrego P, Martínez-Román P, Arca de Lafuente S, Resino S, Taveira N, Briz V*. Sci Rep 2020, 10: 13024. DOI: 10.1038/s41598-020-69692-7.
7. Hepatitis C virus influences HIV-1 viral splicing in coinfected patients. Martínez-Román P, López-Huertas MR, Crespo-Bermejo C, Arca-Lafuente S, Cortegano I, Valle-Millares D, Gaspar ML, Martín-Carbonero, Domínguez-Domínguez L, Ryan P, De los Santos I, De la Fuente Moral S, Fernández-Rodríguez A, Coiras M, Briz V*, on behalf of COVIHEP. J Clin Med 2020, 9 (7): 2091. DOI: 10.3390/jcm9072091.
8. Protist enteroparasites in wild boar (Sus scrofa ferus) and black Iberian pig (Sus scrofa domesticus) in southern Spain: a protective effect on hepatitis E acquisition?
Rivero-Juárez A, Dashti A, López-López P, Salimo Muadica A, Risalde MA, Köster PC, Machuca I, Bailo B, Hernández de Mingo M, Dacal E, García-Bocanegra I, Saugar JM, Calero-Bernal R, González-Barrio D, Rivero A, Briz V, Carmena D. Parasites & Vectors 2020, 13: 281. DOI: 10.1186/s13071-020-04152-9.
9. Comparison of methods and characterization of small RNAs from plasma extracellular vesicles of HIV/HCV coinfected patients. Martinez‑Gonzalez E, Brochado‑Kith O, Gomez‑Sanz A, Martin‑Carbonero L, Jimenez‑Sousa MA, Martinez‑Roman P, Resino S, Briz V#, Fernandez‑Rodriguez A#, Sci Rep 2020, 10: 11140. DOI: 10.1038/s41598-020-67935-1.
10. Epidemiological trend of sepsis in patients with hospital admissions related to hepatitis C in Spain (2000-2015): A nationwide study. Alvaro-Meca A, Mate-Cano I, Ryan P, Resino S#, Briz V#*. J Clin Med 2020, 9(6): 1607. DOI: 10.3390/jcm9061607.
11. Epidemiological trend of hepatitis C-related liver events in Spain (2000-2015): A nationwide population-based study. Mate-Cano I, Alvaro-Meca A, Ryan P, Resino S, Briz V*. Eur J Intern Med. 2020, 75:84-92. DOI: 10.1016/j.ejim.2020.02.002. PMID: 32143898.
12. Nanotechnology: A reality for diagnosis of HCV infectious disease. Arca-Lafuente S, Martínez-Román P, Mate-Cano I, Madrid R, Briz V. Journal of Infection 2020, 80 (1); 8-15. DOI: 10.1016/j.jinf.2019.09.010. PMID: 31580870.
13. Epidemiological trend of hospitalized acute and recurrent hepatitis C in Spain. Mate-Cano I, Alvaro-Meca A, Ryan P, Díaz A, Martínez-Román P, Sánchez-Carrillo M, Resino S, Briz V*. Annals of Medicine 2019, 51 (1); S68-S69. DOI: 10.1080/07853890.2018.1561622.
14. HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study. López-Huertas MR, Palladino C, Garrido-Arquero M, Esteban-Cartelle B, Sánchez-Carrillo M, Martínez-Román P, Martín-Carbonero L, Ryan P, Domínguez-Domínguez L, Santos ID, Moral SDLF, Benito JM, Rallón N, Alcamí J, Resino S, Fernández-Rodríguez A, Coiras M, Briz V*, on behalf of the Multidisciplinary Group of viral coinfection HIV/Hepatitis (COVIHEP). Sci Rep 2019: 9 (1); 5606. DOI: 10.1038/s41598-019-41788-9. PMID: 30944340.
15. Epidemic history of hepatitis C virus genotypes and subtypes in Portugal. Palladino C, Ezeonwumelu IJ, Marcelino R, Briz V, Moranguinho I, Serejo F, Velosa JF, Marinho RT, Borrego P, Taveira N. Sci Reps 2018, 8 (1); 12266. DOI: 10.1038/s41598-018-30528-0. PMID: 30116054.